Impact of Yogotherapeutics on Chronic Pains' Patients

Chronic Pain Clinical Trial

— YOGADO  

Official title:

Impact of Yogotherapeutics in Consultation on Chronic Pains' Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05160181
• Other study ID #: CHRD1119
• Status: Completed
• Start date: September 13, 2021
• Est. completion date: June 28, 2022

Study information

• Verified date: April 2022
• Source: Centre Hospitalier René Dubos
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

In a context where yoga is more and more popularized in France and in Europe, and where Yogatherapy (as complementary medicine) begins to make its place in the care of patients in French hospitals, it seems interesting to study the impact of yoga in the chronic pain patient treated in a specific pain consultation by this non-pharmacological approach, and accessible.

Description:

Yoga is a discipline that has its origins in India for nearly 5,000 years, and which aims to bring physical, mental and spiritual well-being through postures, stretching, breathing exercises and meditation.

Non-invasive and having very few side effects, this approach allows the practitioner to reclaim their body, to know themselves better, to accept their limits, to respect them and to empower themselves in their care and pathology.

More and more studies are now looking at the positive effect of yoga whether it is on stress by demonstrating the drop in cortisol in participants, or on the reduction of symptoms of depression, improvement of immune function, or pain.

To our knowledge, no study of the impact of yoga for analgesic treatment has been carried out in France.

Through this retrospective study, the investigators wish to demonstrate a reduction in pain and / or an improvement in the quality of life.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: June 28, 2022
• Est. primary completion date: June 28, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient = 18 years old,

• Seen in consultation for chronic pain with implementation of Yogatherapy,

Exclusion Criteria:

• Patient < 18 years old,

• No indication for Yogatherapy treatment (Severe cognitive disorder / Major unbalanced psychological disorder),

• Trauma pathology and / or acute fracture in progress,

• Patient refusal to participate.

Related Conditions & MeSH terms

• Chronic Pain

Intervention

Other:
• Yogatherapy
Description: Retrospective study on medical file of patients seen in consultation for chronic pain with prescription of Yogatherapy

Locations

Country	Name	City	State
France	Departement of Chronic Pain Consultation, Hospital René Dubos,	Pontoise

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier René Dubos

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Evolution of the patient's pain	The evolution of the patient's pain is assessed by comparing the pain between the 1st and the 5th consultation, using a numerical scale from 0 to 10 points (0 = no pain and 10 = maximum pain imaginable)	Between the 1st and the 5th consultation, an average of 3 to 5 month
Secondary	Evolution of the patient's pain over time	The evolution of the patient's pain is assessed by comparing the pain between the 1st and the last consultation (number 10 maximum), using a numerical scale from 0 to 10 points (0 = no pain and 10 = maximum pain imaginable)	Between the 1st and the 5th consultation, an average of 3 to 5 month
Secondary	Improvement of patient's sleep	The impact of pain on sleep is evaluated by questioning the patient at the first and last consultation (number 10 maximum) The answer to the question is YES or NO	Between the 1st and the last consultation, an average of 5 to 10 month
Secondary	Evolution of the patient's quality of life	The quality of life is assessed at all visits, by questioning patient, on the following elements: work, daily activities, mood…. to obtain a score on a numerical scale between 0 and 10; Results are interpreted as following : EN = 5 = Very degraded, 6 = EN = 7 = Degraded and EN > 7 = Normal)	Between the 1st and the last consultation, an average of 5 to 10 month
Secondary	Evolution of the patient's therapeutic	The evolution of the therapeutic is evaluated by questioning the patient at the first and last consultation (number 10 maximum) about their treatment: treatment name, indication, dosage, number of doses per day, decrease or increase for each treatment ……. to see if there is a decrease or not in the patient's therapies.	Between the 1st and the last consultation, an average of 5 to 10 month